Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pinoxaden SCHEMBL64416 | 0.87 | ELANE (0.33) | MAPTALDH1A1MAPK1CYP1A2CYP2C9 | |
| Pinoxaden SCHEMBL29359629 | 0.87 | ELANE (0.33) | MAPTALDH1A1MAPK1CYP1A2CYP2C9 | |
| SCHEMBL22959624 | 0.86 | RAB9A (0.34) | MAPTALDH1A1MAPK1KDM4ECYP1A2 | |
| SCHEMBL22940089 | 0.84 | MEN1 (0.30) | MAPTALDH1A1MAPK1KMT2A | |
| Pinoxaden SCHEMBL17187932 | 0.84 | KMT2A (0.32) | MAPTALDH1A1MAPK1TSHRKMT2A | |
| SCHEMBL14088267 | 0.81 | SYK (0.33) | ALDH1A1KDM4EPOLBTP53KMT2A | |
| SCHEMBL5078713 | 0.80 | HSD17B10 (0.38) | MAPTALDH1A1MAPK1RAB9ALMNA | |
| Pinoxaden SCHEMBL2373834 | 0.77 | — | — | |
| Pinoxaden SCHEMBL19463381 | 0.76 | ALDH1A1 (0.39) | MAPTALDH1A1MAPK1KDM4ECYP1A2 | |
| SCHEMBL13672239 | 0.76 | CNR1 (0.36) | MAPTPOLBTSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110066286-B | Phenylpyrazoline compound with biological activity and preparation method and application thereof | 湖南化工研究院有限公司 | 2020-06-16 | — | — | CN | claimed |
| US-20220369641-A1 | MOLECULAR COMPLEXES | MACFARLAN SMITH LIMITED (GB) | 2022-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220369641-A1 | MOLECULAR COMPLEXES | DDT, HPD, PTPRO | MAPT 3498/4885ALDH1A1 3185/4885MAPK1 3127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.